Lawyer profile for USA 2021
Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
Healthcare: Pharmaceutical/Medical Products Regulatory - District of Columbia
"She's excellent to work with. She is very knowledgeable, responsive and great at clearly articulating complicated issues." "A seasoned FDA adviser who is really good at sharing her knowledge." "She understands the way the FDA looks at things and how best to approach them."
This content is provided by Rebecca K. Wood
BECKY WOOD serves on Sidley’s Global Life Sciences Leadership Council and leads Sidley’s Washington, D.C. Healthcare and FDA group. She also has served as Global Lead of the Food, Drug and Medical Device Regulatory practice. Becky focuses her practice on counseling clients on FDA regulatory, enforcement, litigation, and transactional matters. Becky was a founding member of the firm’s COVID-19 Task Force, and advises FDA-regulated clients on a range of COVID-19 response efforts, including Emergency Use Authorizations (EUAs) and immunity considerations under the PREP Act. Becky previously served as Chief Counsel to the Food and Drug Administration (FDA) under former Commissioner Scott Gottlieb. At FDA, she worked on virtually every significant initiative addressed by the Commissioner and agency leadership, including efforts to modernize biopharmaceutical, gene therapy and medical device regulation. This role gives her a unique perspective on today’s regulatory environment, as well as insights into the complex issues that our clients face.